Clinical Trial Update: Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating psilocybin for treatment-resistant depression and chronic pain is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Pain

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Treatment Resistant Depression, Chronic Pain | Phase 2 | Status: RECRUITING